<SEC-DOCUMENT>0001140361-20-002973-index.html : 20200212
<SEC-HEADER>0001140361-20-002973.hdr.sgml : 20200212
<ACCEPTANCE-DATETIME>20200212172415
ACCESSION NUMBER:		0001140361-20-002973
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200212
DATE AS OF CHANGE:		20200212

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Intellia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001652130
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				364785571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89486
		FILM NUMBER:		20605626

	BUSINESS ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-6200

	MAIL ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nikko Asset Management Americas, Inc.
		CENTRAL INDEX KEY:			0001480751
		IRS NUMBER:				941302123
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0310

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		605 THIRD AVENUE
		STREET 2:		38TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10158
		BUSINESS PHONE:		212-610-6100

	MAIL ADDRESS:	
		STREET 1:		605 THIRD AVENUE
		STREET 2:		38TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10158
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>formsc13ga.htm
<DESCRIPTION>SC 13G/A
<TEXT>
Document 1 - file: formsc13ga.htm

</DOCUMENT>
</SEC-DOCUMENT>